COMMUNIQUÉS West-GlobeNewswire

Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
17/11/2025
Daix (France), New York City (New York, United States), November 17, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]
Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de l'Offre à environ 172,5 millions de dollars
17/11/2025
Daix (France), New York City (New York, États-Unis), le 17 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Nxera Announces Focused Restructuring to Enhance Path to Profitability
17/11/2025
Tokyo, Japan and Cambridge and London, UK, 17 November 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announced a focused restructuring designed to concentrate investment and resources on [...]
TME Pharma announces receipt of agreements in principle to extend certain bond agreements
17/11/2025
TME Pharma announces receipt of agreements in principle to extend certain bond agreements Berlin, Germany , November 17, 2025, 08.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology [...]
TME Pharma announces receipt of agreements in principle to extend certain bond agreements
17/11/2025
TME PHARMA ANNONCE AVOIR REÇU DES ACCORDS DE PRINCIPE POUR PROLONGER CERTAINS ACCORDS D'OBLIGATIONS Berlin, Allemagne, le 17 novembre 2025, 8h00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de [...]
James M. O’Brien Appointed Chief Financial Officer at Mesoblast
17/11/2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company’s [...]
Ascend Vitality Expands National Telehealth Network to Provide Physician-Directed Access to Compounded Peptide Therapies
17/11/2025
Sheridan, WY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Ascend Vitality announced today that it has expanded its fully licensed telehealth operations across all 50 states, reinforcing its position as a provider of physician- [...]
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
17/11/2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US FDA clearance now allows use of the ARC-EX ® System both in clinics and homes ARC- [...]
CFO Tania Micki to leave Tecan for new role in 2026
17/11/2025
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, November 17, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that Tania Micki, Chief [...]
Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease
17/11/2025
-- STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm gut-restricted profile of ontunisertib in FSCD patients -- -- Positive efficacy [...]
No Crap In It Launches Limited Holiday Christmas Collection and New Primal Super Blend Supplement, Expanding Its All-Natural Wellness Line
17/11/2025
Willis, TX, Nov. 16, 2025 (GLOBE NEWSWIRE) -- No Crap In It, an all-natural wellness and beauty brand proudly made in Texas has announced the launch of its Limited Holiday Collection – a festive new line of clean label [...]
Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy
16/11/2025
Shareholders approved all proposals, confirming Faraday Future Intelligent Electric Inc. (“Faraday Future”) as the Company’s new majority and controlling shareholder. Faraday Future will nominate a majority of board [...]
NooCube | Nootropics Brain Booster 2025: Lunch Noocube Brain Productivity Pills for Memory, Focus, Read Ingredients & Side Effects.
16/11/2025
NooCube Effective Nootropics Brain Health Supplement Read NooCube ingredients, Side Effects, Benefits | Does the NooCube really work? New York City, Nov. 16, 2025 (GLOBE NEWSWIRE) -- November 14, 2025, Noocube Brain [...]
Vnzymes Opens New European Office in Frankfurt to Accelerate Innovation in Animal Nutrition and Sustainable Agriculture
15/11/2025
FRANKFURT, Germany, Nov. 15, 2025 (GLOBE NEWSWIRE) -- Vnzymes, the new brand and European subsidiary of VTR Biotech Group, today officially announced the grand opening of its office in Frankfurt, marking a significant [...]
Sapphire RX Expands Access to Virtual Wellness Care
15/11/2025
KNOXVILLE, Tenn., Nov. 15, 2025 (GLOBE NEWSWIRE) -- Sapphire RX advances digital health accessibility with an innovative telehealth model that prioritizes patient privacy, medical oversight, and personalized care for [...]
Algernon Closes First Tranche of its Recently Announced Private Placement Financing
15/11/2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) ( [...]
Avicanna Reports Q3 2025
14/11/2025
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company” ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization [...]
Range Impact Reports 3Q 2025 Financial Results
14/11/2025
Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in [...]
COSCIENS Biopharma Inc. Announces Leadership Change
14/11/2025
TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and pharmaceutical solutions, [...]

Pages